Diabetes Mellitus e fator de risco genético - uma pequena revisão / Diabetes Mellitus and genetic risk factor - a small review
DOI:
https://doi.org/10.34119/bjhrv4n5-399Keywords:
Diabetes Mellitus, Fatores de Risco, Genéticos.Abstract
Introdução: O desenvolvimento do Diabetes Mellitus (DM) pode ser associado a vários fatores como genético e ambiental. Estudos sobre os fatores genéticos estão associados ao auxílio no diagnóstico e melhoria no tratamento do DM. Objetivo: Este estudo teve como objetivo realizar uma revisão sistemática sobre o fator de risco genético relacionado ao DM. Método: A revisão foi conduzida nas bases de dados PubMed, CINAHL e SCOPUS, no período correspondido entre 2019 e 2021. Para a busca dos artigos, os descritores utilizados foram “diabetes mellitus”, “genetics” e, “risk factors”, além de associações entre eles utilizando o indicador booleano “AND”. Resultados: Foram selecionados um total de 13 artigos para compor esta revisão sendo 6 artigos para DM1 e 7 artigos para DM2. Conclusão: Foi concluída a importância da investigação genética no diagnóstico do DM adicionado à informação da história familiar, perfil clínico e estilo de vida como dieta e atividade física. A observação de genes já conhecidos e de novas mutações, bem como proteínas associadas ao DM podem auxiliar no diagnóstico, classificação, tratamento individual e, no auxílio para controle, prevenindo as complicações tardias associadas ao DM e, visando melhor qualidade de vida.
References
Lyra R, Oliveira M, Lins D, Cavalcanti N, Gross JL, Maia FFR, et al. Sociedade Brasileira de Diabetes. Vol. 5, Diabetes Mellitus Tipo 1 e Tipo2. 2020. 709–717 p.
Kazi AA, Blonde L. Classification of diabetes mellitus. Vol. 21, Clinics in Laboratory Medicine. 2001. 1–13 p.
Tests D, Diabetes FOR. 2. Classification and diagnosis of diabetes. Diabetes Care. 2015;38(January):S8–16.
Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract [Internet]. 2019;157:107843. Available from: https://doi.org/10.1016/j.diabres.2019.107843
Temneanu OR, Trandafir LM, Purcarea MR. Type 2 diabetes mellitus in children and adolescents: a relatively new clinical problem within pediatric practice. J Med Life. 2016;9(3):235–9.
Castro RMF de, Silva AM do N, Silva AK dos S da, Araújo BFC de, Maluf BVT, Franco JCV. Diabetes mellitus e suas complicações - uma revisão sistemática e informativa/ Diabetes mellitus and its complications - a systematic and informative review. Brazilian J Heal Rev. 2021;4(1):3349–91.
O’Neill KN, McHugh SM, Tracey ML, Fitzgerald AP, Kearney PM. Health service utilization and related costs attributable to diabetes. Diabet Med. 2018;35(12):1727–34.
Tremblay J, Hamet P. Environmental and genetic contributions to diabetes. Metabolism. 2019;100:1–6.
Ding L, Fan L, Xu X, Fu J, Xue Y. Identification of core genes and pathways in type 2 diabetes mellitus by bioinformatics analysis. Mol Med Rep. 2019;20(3):2597–608.
Ayelign B, Negash M, Andualem H, Wondemagegn T, Kassa E, Shibabaw T, et al. Association of IL-10 (? 1082 A/G) and IL-6 (? 174 G/C) gene polymorphism with type 2 diabetes mellitus in Ethiopia population. BMC Endocr Disord. 2021;21(1):4–11.
Triolo TM, Fouts A, Pyle L, Yu L, Gottlieb PA, Steck AK. Identical and nonidentical twins: Risk and factors involved in development of islet autoimmunity and type 1 diabetes. Diabetes Care. 2019;42(2):192–9.
Yu MG, Keenan HA, Shah HS, Frodsham SG, Pober D, He Z, et al. Residual ? cell function and monogenic variants in long-duration type 1 diabetes patients. J Clin Invest. 2019;129(8):3252–63.
Galavi H, Mollashahee-Kohkan F, Saravani R, Sargazi S, Noorzehi N, Shahraki H. HHEX gene polymorphisms and type 2 diabetes mellitus: A case-control report from Iran. J Cell Biochem [Internet]. 2019;120(10):16445–51. Available from: http://dx.doi.org/10.1002/jcb.28788
Cheng F, Liu L, Zhang H, Zhu Y, Li X, Li H. Association of IL-16 gene polymorphisms with the risk of developing type 2 diabetes mellitus in the Chinese Han population. Biosci Rep. 2019;39(8):1–7.
Adamska-Patruno E, Samczuk P, Ciborowski M, Godzien J, Pietrowska K, Bauer W, et al. Metabolomics Reveal Altered Postprandial Lipid Metabolism after a High-Carbohydrate Meal in Men at High Genetic Risk of Diabetes. J Nutr. 2019;149(6):915–22.
Li Y, Li C, Yang M, Shi L, Tao W, Shen K, et al. Association of single nucleotide polymorphisms of miRNAs involved in the GLUT4 pathway in T2DM in a Chinese population. Mol Genet Genomic Med. 2019;7(9):1–11.
Vehik K, Bonifacio E, Lernmark Å, Yu L, Williams A, Schatz D, et al. Hierarchical order of distinct autoantibody spreading and progression to type 1 diabetes in the Teddy study. Diabetes Care [Internet]. 2020;43(9):2066–73. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85090043666&doi=10.2337%2Fdc19-2547&partnerID=40&md5=0c7b40f219e5f957ae5f07464a410ad2
Beyerlein A, Bonifacio E, Vehik K, Hippich M, Winkler C, Frohnert BI, et al. Progression from islet autoimmunity to clinical type 1 diabetes is influenced by genetic factors: Results from the prospective TEDDY study. J Med Genet [Internet]. 2019;56(9):602–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85054379240&doi=10.1136%2Fjmedgenet-2018-105532&partnerID=40&md5=8da0fda76fec9102d2d34ad26456e0cb
Krischer JP, Liu X, Vehik K, Akolkar B, Hagopian WA, Rewers MJ, et al. Predicting islet cell autoimmunity and type 1 diabetes: An 8-year teddy study progress report. Diabetes Care [Internet]. 2019;42(6):1051–60. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85066448751&doi=10.2337%2Fdc18-2282&partnerID=40&md5=f8bf9a0261ef874c490382126d2bf345
Hippich M, Beyerlein A, Hagopian WA, Krischer JP, Vehik K, Knoop J, et al. Genetic contribution to the divergence in type 1 diabetes risk between children from the general population and children from affected families. Diabetes [Internet]. 2019;68(4):847–57. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85063639692&doi=10.2337%2Fdb18-0882&partnerID=40&md5=0aeda3e0c23f69dc5abf65daabf39770
Miguel-Escalada I, Bonàs-Guarch S, Cebola I, Ponsa-Cobas J, Mendieta-Esteban J, Atla G, et al. Human pancreatic islet three-dimensional chromatin architecture provides insights into the genetics of type 2 diabetes. Nat Genet [Internet]. 2019;51(7):1137–48. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85068310158&doi=10.1038%2Fs41588-019-0457-0&partnerID=40&md5=84f554de2f31f62633d948e3a3bafc45
Ilonen J, Lempainen J, Veijola R. The heterogeneous pathogenesis of type 1 diabetes mellitus. Nat Rev Endocrinol [Internet]. 2019;15(11):635–50. Available from: http://dx.doi.org/10.1038/s41574-019-0254-y
Siljander H, Honkanen J, Knip M. Microbiome and type 1 diabetes. EBioMedicine [Internet]. 2019;46:512–21. Available from: https://doi.org/10.1016/j.ebiom.2019.06.031
Sociedade Brasileira de Diabetes. Abordagem da Pessoa Jovem com Diabetes 2019/2020. 2019;2(2):40.
Mohan V, Das AK, Mukherjee JJ, Seshadri K, Jha S, Kalra S. From individualized to personalized medicine in diabetes: An expert overview. J Assoc Physicians India. 2019;67:78–82.
Valkovicova T, Skopkova M, Stanik J, Gasperikova D. Novel insights into genetics and clinics of the HNF1A-MODY. Endocr Regul. 2019;53(2):110–34.
Bonifacio E, Hummel M, Walter M, Schmid S, Ziegler AG. IDDM1 and multiple family history of type 1 diabetes combine to identify neonates at high risk for type 1 diabetes. Diabetes Care. 2004;27(11):2695–700.
Tait KF, Marshall T, Berman J, Carr-Smith J, Rowe B, Todd JA, et al. Clustering of autoimmune disease in parents of siblings from the Type 1 diabetes Warren repository. Diabet Med. 2004;21(4):358–62.
Bansal V, Gassenhuber J, Phillips T, Oliveira G, Harbaugh R, Villarasa N, et al. Spectrum of mutations in monogenic diabetes genes identified from high-throughput DNA sequencing of 6888 individuals. BMC Med. 2017;15(1):1–14.
Wang D, Pan G. The Association between rs2292239 Polymorphism in ERBB3 Gene and Type 1 Diabetes: A Meta-Analysis. Biomed Res Int. 2019;2019:1–7.
Winkler C, Haupt F, Heigermoser M, Zapardiel-Gonzalo J, Ohli J, Faure T, et al. Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials—GPPAD-02 study design and first results. Pediatr Diabetes. 2019;20(6):720–7.
Pearson ER. Type 2 diabetes: a multifaceted disease. Diabetologia. 2019;62(7):1107–12.
Mambiya M, Shang M, Wang Y, Li Q, Liu S, Yang L, et al. The Play of Genes and Non-genetic Factors on Type 2 Diabetes. Front Public Heal. 2019;7(November):1–8.
Heideman WH, Middelkoop BJC, Nierkens V, Stronks K, Verhoeff AP, Van Esch SCM, et al. Changing the odds. What do we learn from prevention studies targeted at people with a positive family history of type 2 diabetes? Prim Care Diabetes [Internet]. 2011;5(4):215–21. Available from: http://dx.doi.org/10.1016/j.pcd.2011.06.004
Cuschieri S. The genetic side of type 2 diabetes – A review. Diabetes Metab Syndr Clin Res Rev [Internet]. 2019;13(4):2503–6. Available from: https://doi.org/10.1016/j.dsx.2019.07.012
Javierre BM, Sewitz S, Cairns J, Wingett SW, Várnai C, Thiecke MJ, et al. Lineage-Specific Genome Architecture Links Enhancers and Non-coding Disease Variants to Target Gene Promoters. Cell. 2016;167(5):1369-1384.e19.
Cairns J, Freire-Pritchett P, Wingett SW, Várnai C, Dimond A, Plagnol V, et al. CHiCAGO: Robust detection of DNA looping interactions in Capture Hi-C data. Genome Biol [Internet]. 2016;17(1):1–17. Available from: http://dx.doi.org/10.1186/s13059-016-0992-2
